Medication info
Jepazine Duo Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Jepazine Duo Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablet with a light brownish purple color.
Packaging
Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]
Approval status
Active

MFDS item code 202501818 · Approved 2025.07.17 · Insurance code 645406570

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose glycemic control is inadequate with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min, provided they do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered using this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom This Medicine Must Not Be Used, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
  • cardiovascular disease
View approved original text

This medication is used to improve blood sugar control in adult patients with type 2 diabetes by complementing dietary and exercise therapy. It is particularly administered when blood sugar is not adequately controlled, and caution is required for patients with cardiovascular disease regarding the occurrence of cardiovascular events. Therefore, this medication is effectively used for managing blood sugar levels in type 2 diabetes.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose glycemic control is inadequate with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min, provided they do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered using this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom This Medicine Must Not Be Used, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains two components that help control blood sugar. However, there are several points to be cautious about while taking this medication. First, it may be dangerous for individuals with poor kidney function, so it is essential to confirm that kidney function is normal. Additionally, it is not advisable to use this medication in patients with severe infections, dehydration, or heart and kidney issues such as heart failure. This medication can cause hypoglycemia, especially when taken with insulin or other blood sugar-lowering agents; hence, caution is advised. If symptoms of too low blood sugar appear, consult a doctor immediately. Furthermore, it may not be suitable for patients with impaired liver function. Excessive alcohol intake can also increase the risk of side effects, so it should be avoided. Pregnant or potentially pregnant women and those who are breastfeeding should not take this medication. During the use of this medication, urinary tract infections or genital infections may occur; therefore, if related symptoms arise, prompt treatment is essential. This medication may lower Vitamin B12 levels; regular checking of Vitamin B12 levels is advisable for those on long-term use. If undergoing surgery or tests involving iodine contrast agents, the use of this medication should be temporarily suspended and restarted only after kidney function has returned to normal. Elderly patients or those at risk of fluid loss should be cautious of dehydration or low blood pressure, and regular monitoring of kidney function and fluid status is important. Finally, consult healthcare professionals promptly if you notice any changes in symptoms or unusual reactions during the intake of this medication.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 123 more
  • abnormal liver function tests
  • hepatitis
  • dysgeusia
  • pruritus
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • vaginismus
  • vulvitis
  • balanitis
  • perineal necrosis
  • decreased fluid volume
  • ketoacidosis
  • lactic acidosis
  • headache
  • dizziness
  • insomnia
  • fever
  • chest discomfort
  • chest pain
  • weakness
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • vascular stent stenosis
  • vascular stent thrombosis
  • urinary stones
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • anxiety
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • postural vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diabetic foot
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • exudative retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular disorder
  • peripheral artery obstructive disease
  • unstable angina
  • anxiety
  • depression
  • sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Maintaining the storage temperature between 1 degree and 30 degrees Celsius at room temperature is crucial. Proper storage will ensure the medication's efficacy is safely preserved.

Appearance and packaging

Appearance

Biconvex oval film-coated tablet with a light brownish purple color.

Package unit

Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.